Molecular Dynamics will present its revolutionary whole body CZT digital SPECT/CT solution at RSNA 2015.
The company will introduce the Valiance X12 system, a breakthrough improvement over the currently available general purpose analog SPECT technology. The Valiance X12 delivers high resolution, low dose, high speed personalized images, based on a unique imaging platform and proprietary imaging algorithms designed to deliver results comparable to PET at a lower cost.
“We are excited about the introduction of the Valiance X12 at RSNA” said Din Hadass, Molecular Dynamics Israel’s COO. “Innovative features including adaptive image acquisition that focuses the detectors on specific organs, combined with simultaneous multiple isotope and online dynamic imaging capabilities allow the Valiance X12 to tailor the imaging process to individual patients and collect more data from each scan.”
The advanced features, combined with superior accuracy at high count rates are designed to enable unprecedented absolute quantification for therapy planning and monitoring. The system simultaneously improves image quality, scan time and patient dose.
“Our innovative CZT-based technology and advanced applications will provide physicians with cost-effective personalized-medicine solutions, leading to more accurate diagnoses and, ultimately, better clinical outcomes,” said Shlomo Ben-Haim, founder of Molecular Dynamics.
For more information: www.molecular-d.com
February 13, 2026 
